AMN Healthcare Services, Inc. (AMN) SEC Filings & Earnings Calls
EquiReason read 9 AMN Healthcare Services, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Revenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.9B
- P/E TTM
- 17.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
7 Aug 202610-QRevenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6open
Figures in the filing · each found in the filing text
| Revenue · consolidated · Q2-2026 | $673M | +2% y/y |
| Revenue · consolidated · H1-2026 | $2.05B | +52% y/y |
| Gross margin · consolidated · Q2-2026 | 30.6% | |
| Net cash provided by operating activities · consolidated · H1-2026 | $373M | +118% y/y |
| Average travelers on assignment · nurse_and_allied_solutions · Q2-2026 | 6.0% | |
| Days filled (locum tenens) · physician_and_leadership_solutions · Q2-2026 | -8.0% |
Risks flagged
Labor disruption revenue volatility
“Even if somewhat recurrent over the long term, labor disruption events are unpredictable and have driven spikes in demand and related financial outcomes when they happen.” · word for word
Pricing pressure in language services
“Ongoing pricing pressure for language services continues to be a headwind due to increased market competition.” · word for word
Client losses in VMS business
“our VMS business declined $3.9 million (or 20%) due to lower staffing utilization on the platforms along with several client losses.” · word for word
8 May 202610-QRevenue $1.38B (+100% y/y); Nurse and allied solutions revenue $1.13B (+173% y/y); Physician and leadership solutions revenue $164M (-6% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $1.38B | +100% y/y |
| Nurse and allied solutions revenue · Nurse and allied solutions · Q1-2026 | $1.13B | +173% y/y |
| Physician and leadership solutions revenue · Physician and leadership solutions · Q1-2026 | $164M | -6% y/y |
| Technology and workforce solutions revenue · Technology and workforce solutions · Q1-2026 | $87M | -15% y/y |
| Gross profit · Q1-2026 | $369M | +86% y/y |
| Gross margin · Q1-2026 | 26.8% | |
| Operating cash flow · Q1-2026 | $562M | +507% y/y |
| Average travelers on assignment · Nurse and allied solutions · Q1-2026 | 3.0% | |
| Average bill rate · Nurse and allied solutions · Q1-2026 | 6.0% |
Risks flagged
Language Services Pricing Pressure
“Ongoing pricing pressure for language services is expected due to increased market competition.” · word for word
Physician and Leadership Solutions Demand Weakness
“Demand for our locum tenens staffing business in the first quarter increased slightly from prior year but decreased sequentially.” · word for word
VMS Business Decline
“Revenue for our VMS business declined $3.5 million (or 18%) due to lower staffing utilization on the platforms along with several client losses.” · word for word
18 Mar 2026DEF 14AAdjusted EBITDA $234M (-29% y/y); Free Cash Flow $269M; Net Debt Reduction $285M; Guidance: 2026 bonus structure modified: 45% Pre-Bonus AEBITDA, 25% revenue, 30% leadershipopen
Figures in the filing · each found in the filing text
| Adjusted EBITDA · FY2025 | $234M | -29% y/y |
| Free Cash Flow · FY2025 | $269M | |
| Net Debt Reduction · FY2025 | $285M | |
| Pre-Bonus Adjusted EBITDA · FY2025 | $243M | |
| Nurse & Allied Solutions Revenue · Nurse & Allied Solutions · FY2025 | $1.65B | |
| Physician & Leadership Solutions Revenue · Physician & Leadership Solutions · FY2025 | $696M | |
| Technology & Workforce Solutions Revenue · Technology & Workforce Solutions · FY2025 | $387M | |
| Passport Registered Users · 2025-12-31 | 340,000 | |
| Client Satisfaction Score · FY2025 | 92.0% |
Guidance
2026 bonus structure modified: 45% Pre-Bonus AEBITDA, 25% revenue, 30% leadership
Management expects improved business trends in 2026 but acknowledges ongoing challenges. No specific revenue or EPS guidance provided.
Risks flagged
Policy Uncertainty Risk
“Clients remain focused on cost containment, reimbursement rates are pressured, and policy uncertainty persists.” · word for word
Revenue Decline Risk
“Revenue declined by 8%” · word for word
Margin Compression Risk
“Consolidated Adjusted EBITDA declined by 29%” · word for word
Credit Rating Downgrade Risk
“Moody’s and Fitch Ratings have both downgraded AMN’s credit ratings in 2025.” · word for word
20 Feb 202610-KMSP spend under management $1.80B; VMS spend flow $1.40B; Passport registered users 340,000open
Figures in the filing · each found in the filing text
| MSP spend under management · Technology and Workforce Solutions · FY2025 | $1.80B | |
| VMS spend flow · Technology and Workforce Solutions · FY2025 | $1.40B | |
| Passport registered users · January 2026 | 340,000 |
Risks flagged
Client concentration risk (Kaiser 22% of revenue)
“Kaiser Foundation Hospitals (and its affiliates) comprised approximately 22% of our consolidated revenue in 2025.”
Economic downturn impact on demand
“Demand for staffing services is sensitive to changes in economic activity. Many healthcare facilities utilize temporary healthcare professionals to accommodate an increase in hospital admissions. Conversely, when hospital admissions decrease in economic downturns or periods of high inflation, due to reduced consumer spending, the demand for our temporary hea” · word for word
Independent contractor classification risk
“Historically, we have treated our locum tenens, which include physicians and certain advanced practitioners, such as certified nurse anesthetists, nurse practitioners and physician assistants, as independent contractors.” · word for word
5 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Board transition risk: Low; routine retirement and nomination.
“Departure not due to disagreement; successor identified.”
7 Nov 202510-QRevenue $634M (-8% y/y); Gross Margin 29.1; Operating Cash Flow $194M (-22% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $634M | -8% y/y |
| Gross Margin · Q3-2025 | 29.1% | |
| Operating Cash Flow · 9M-2025 | $194M | -22% y/y |
| Nurse and Allied Solutions Revenue · nurse_and_allied_solutions · Q3-2025 | $361M | -9% y/y |
| Physician and Leadership Solutions Revenue · physician_and_leadership_solutions · Q3-2025 | $178M | -1% y/y |
| Technology and Workforce Solutions Revenue · technology_and_workforce_solutions · Q3-2025 | $95M | -12% y/y |
Risks flagged
Healthcare Staffing Demand Decline
“Revenue decreased 8% to $634.5 million for the three months ended September 30, 2025 from $687.5 million for the same period in 2024.” · word for word
Gross Margin Compression
“Gross profit decreased 13% to $184.4 million for the three months ended September 30, 2025 from $213.1 million for the same period in 2024, representing gross margins of 29.1% and 31.0%, respectively.” · word for word
Goodwill Impairment
“A goodwill impairment loss of $109.5 million was recognized in the physician and leadership solutions segment during the nine months ended September 30, 2025.” · word for word
Intangible Asset Impairment
“An impairment loss of $18.3 million was recognized for intangible assets during the nine months ended September 30, 2025.” · word for word
Language Services Pricing Pressure
“Ongoing pricing pressure for language services is expected due to increased market competition.” · word for word
6 Nov 20258-K · 2.02Revenue $634M (-8% y/y); Gross profit $184M (-13% y/y); Net income $29M (+319% y/y); Guidance: Q4 revenue $715M-$730M; adjusted EBITDA margin 6.8%-7.3%earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $635M | -8% y/y |
| Gross profit · Q3-2025 | $184M | -13% y/y |
| Net income · Q3-2025 | $29M | +319% y/y |
| Adjusted diluted EPS · Q3-2025 | $0.39 | -36% y/y |
| Adjusted EBITDA · Q3-2025 | $58M | -22% y/y |
| Cash flow from operations · Q3-2025 | $23M |
Guidance
Q4 revenue $715M-$730M; adjusted EBITDA margin 6.8%-7.3%
Q4 revenue expected to grow sequentially but margins remain under pressure.
Risks flagged
Revenue decline across all segments; gross margin compression; reliance on labor disruption events for growth.
“Revenue -8% YoY; gross margin -190bps; labor disruption revenue $12M in Q3, assumed ~$100M in Q4.”
AMN Healthcare Services, Inc. — questions
- What did AMN Healthcare Services, Inc. file recently?
- 9 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Revenue $673M (+2% y/y); Revenue $2.05B (+52% y/y); Gross margin 30.6
Every figure on this page comes from AMN Healthcare Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.